CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale President sold 9,537 shares at an average $1.95 ($18,612)
- 4 Open-market sale See Remarks sold 5,276 shares at an average $1.95 ($10,296)
- 4 Open-market sale Chief Executive Officer sold 14,638 shares at an average $1.95 ($28,566)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
- 4 Open-market buy Director bought 646,204 shares at $3.10 ($2,003,232)
- 4 Open-market buy Director bought 646,204 shares at $3.10 ($2,003,232)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 200 shares at $2.70 ($540)
- 8-K Event Material agreement · Unregistered share sale · Other events
- 424B5 Offering Prospectus
- 10-K/A Report 10-K/A
Page 18 of 31 · 616 filings